Boston Scientific halted the sales of its second-generation Watchman FLX in Europe because of higher-than-expected embolism rates. The complication resulted in one death that was linked to postoperative infection after the device was percutaneously removed.
Life April 6, 2016
A jury from Delaware adjudged Boston Scientific guilty and ordered it to pay $100 million to 51-year-old Deborah Barba as compensatory and punitive damages.
Life May 29, 2015
Boston Scientific's Watchman Left Atrial Appendage Closure (LAAC) Device intends to prevent stroke. It is a non-drug substitute for Warfarin.
Life March 16, 2015
Endo International sells its men's health and prostate business to Boston Scientific. The deal is worth $1.65 billion, which is expected to close in the third quarter of this year.
Life March 3, 2015
Boston Scientific has been in a lot of hot water since it acquired Guidant in 2006. With this settlement, it is finally making peace with Johnson & Johnson and moving on.
Life February 20, 2015